In addition, we demonstrated that EGF show different functionality than NGF or GDNF and that EGF is a new potential analgesic modulator in the process of pain sensitization, a result of importance not least in the light of the increased use EGFR blockers for therapeutic cancer treatment. This evidence concerns the gene EGFR and cancer.